Detalles de la búsqueda
1.
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Mol Cancer
; 23(1): 115, 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811992
2.
The finer details? The predictability of life outcomes from Big Five domains, facets, and nuances.
J Pers
; 90(2): 167-182, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34236710
3.
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(9): 1275-1289, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363762
4.
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol
; 22(7): 1034-1046, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34143970
5.
Constructing surface models of silicate glasses using molecular dynamics to understand the effect of pH on the hydration properties.
J Chem Phys
; 150(17): 174703, 2019 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31067871
6.
Conformation-controlled hydrogen storage in the CAU-1 metal-organic framework.
Phys Chem Chem Phys
; 18(42): 29258-29267, 2016 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27731468
7.
Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges.
J Cardiovasc Magn Reson
; 17: 20, 2015 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25827408
8.
Synthesis and properties of lanthanide ruthenium(III) oxide perovskites.
Angew Chem Int Ed Engl
; 53(32): 8343-7, 2014 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24962649
9.
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Cancer Cell
; 42(2): 209-224.e9, 2024 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215748
10.
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
J Clin Oncol
; 41(1): 43-53, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737919
11.
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.
JAMA Oncol
; 9(1): 40-50, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394849
12.
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study.
J Thorac Oncol
; 18(11): 1594-1606, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390980
13.
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 29(11): 2066-2074, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806911
14.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
JAMA Oncol
; 9(1): 29-39, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394867
15.
NHS connecting for health: healthcare professionals, mobile technology, and infection control.
Telemed J E Health
; 18(4): 289-91, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22428552
16.
A template-free, more environmentally friendly approach for glass micro-texturing.
Sci Rep
; 12(1): 879, 2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042951
17.
Does Cancer Type Influence the Impact of Recurrence? A Review of the Experience of Patients With Breast or Prostate Cancer Recurrence.
Front Psychol
; 12: 635660, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34267696
18.
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer.
MAbs
; 13(1): 1857100, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397194
19.
Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.
Invest New Drugs
; 28(5): 561-74, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19626278
20.
Development of PARP and Immune-Checkpoint Inhibitor Combinations.
Cancer Res
; 78(24): 6717-6725, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30498083